AdvaMedDx® COVID-19 Testing Infographic
This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.
Diagnostics
Learn more about our Diagnostics work.
VALID Act 2020 Comprehensive Summary
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
Diagnostics Manufacturers Ramping Up COVID-19 Tests to Combat Pandemic
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
AdvaMedDx® VALID Act Webinar, March 20, 2020 – Presentation
On March 5, 2020, the VALID Act was introduced in the Senate and House.
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
LAB Act Passage a Critical Step Forward for Diagnostic Sector of Medtech Industry
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
From Test To Treatment: The Value Of Diagnostics
AdvaMedDx® Test to Treatment fact sheets and social media-ready value facts communicate the value of diagnostics.
Reps. Peters, Bilirakis, Pascrell, Schrader, Holding and Hudson Introduce Bipartisan Legislation to Protect Seniors’ Lab Benefits, Improve Data Reporting Under PAMA
LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. — With 53 million Americans facing steep year-over-year cuts…
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers…